This systematic review and meta-analysis quantifies the association between concurrent statin use and overall and prostate cancer−specific mortality among men undergoing androgen-ablative therapies for advanced prostate cancer.
Recent Posts
- Coseropositivity to Tick-Borne Pathogens in Patients Suspected to Have Lyme Disease
- Urban and Rural Hospital Closures in Georgia, 2022-2024
- Single- vs Multiple-Dose Antibiotic Prophylaxis for Total Hip Arthroplasty
- Maternal Outcomes Among Periviable Births by Cesarean Delivery
- RSV Vaccine Effectiveness Among US Older Adults, 2023-2024 Season